J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Red 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
Robots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem
The right level of trust in the scientific literature
An overreliance on what’s gone before can hinder innovation
Materials strategy for UK needs chemistry to succeed and create new industries
Athira pharma settles research misconduct charges for $4 million
The promise of drugs that send proteins to the shredder
Re-establishing my scientist identity in industry
EPA concludes that formaldehyde presents ‘unreasonable risk’ to human health
US state charges Lockhart director over river chemical release
Highlights
The promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
Chemicals industry roundup 2024
Europe continues to struggle with high energy and feedstock costs, while US and Asia negotiate supply gluts
Pharmaceuticals roundup 2024
Diabetes and weight loss drugs have surged in popularity, revealing supply frailties
Opposition to lithium mines hampers green technology supply chain
Europe and US seek to escape Chinese dominance in critical minerals
Forty years on from the Bhopal disaster what lessons have been learnt?
India looks to the future as survivors fight on to receive adequate compensation and medical care
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Robots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem
Athira pharma settles research misconduct charges for $4 million
Deal with US Department of Justice resolves allegations against former chief executive
The promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Red 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
Sharing the burden of contraception could also mean sharing the risk
What if risk assessments for contraception considered the sum of risk to both members of a couple?
Athira pharma settles research misconduct charges for $4 million
Deal with US Department of Justice resolves allegations against former chief executive
EPA concludes that formaldehyde presents ‘unreasonable risk’ to human health
Agency will propose new regulatory actions to reduce health risks associated with the compound’s industrial uses
US state charges Lockhart director over river chemical release
Bankrupt firm’s leader accused of endangering the public and altering public records
Metal–organic framework captures carbon dioxide at industrially relevant temperatures
Material could improve energy efficiency of capturing carbon from industy’s exhaust gases
Fluorspar to fluorine chemicals without going via hazardous hydrogen fluoride
Safer way to turn calcium fluoride mineral into valuable industrial materials
Banned pigments found in tattoo inks sold in the EU
Nine out of 10 green and blue inks analysed violate Reach regulations
Nanopore sequencing set to transform our understanding of proteins
Rapid sequencing technique can not only deal with proteins hundreds of amino acids long but can detect modifications
How F1 plans to transition to ‘100% sustainable fuel’
Rule changes intend to make Formula One more environmentally friendly from 2026. But what are the changes, and can a sport known for gas-guzzling engines really go green?
PFAS-free synthesis of fluorinated drugs and pesticides
Flow chemistry introduces trifluoromethyl group onto a range of compounds using just caesium fluoride as the fluorine source
Potential new class of antibiotics takes on flesh-eating infections
Peptide-mimicking compounds target bacterial cell walls
Innovative antibacterial strategy shows promise for treating infections
New antibiotic mechanism sees molecule infiltrate bacterial cells and destroy them from the inside
US aims to reinstate chlorpyrifos insecticide ban
2021 ban on remaining food uses was overturned on appeal in 2023
Forty years on from the Bhopal disaster what lessons have been learnt?
India looks to the future as survivors fight on to receive adequate compensation and medical care
Chemicals industry roundup 2024
Europe continues to struggle with high energy and feedstock costs, while US and Asia negotiate supply gluts
Maintenance error led to deadly hydrogen sulfide leak
Workers opened live pipework 1.5m away from intended work site
Red 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
US state charges Lockhart director over river chemical release
Bankrupt firm’s leader accused of endangering the public and altering public records
PFAS manufacturers sued for deceptive marketing in US
Texas attorney general accuses 3M and DuPont of knowingly concealing health risks
Chemicals industry roundup 2024
Europe continues to struggle with high energy and feedstock costs, while US and Asia negotiate supply gluts
Deadly explosion at US food colouring plant
2 workers dead, 11 injured at Givaudan Sense Colour in Louisville
Adnoc to buy Covestro, continuing expansion into polymers
€15 billion deal sees Gulf oil producer looking to future growth beyond fuels
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Sanofi spins out its consumer healthcare business
US-based investment firm takes controlling stake in Opella, while France’s government moves to ensure the company remains in the country
Adnoc to buy Covestro, continuing expansion into polymers
€15 billion deal sees Gulf oil producer looking to future growth beyond fuels
Weight-loss drugmakers bet billions on boosting supplies
Eli Lilly and Novo Nordisk invest to expand in-house manufacturing of GLP-1 drugs
Digital tools for deft materials development
Discover how Microsoft can help you turn years of lab work into days of computation
Infographic: become a lab of the future
Save time and money by maximizing your lab productivity anytime, from anywhere
PFAS analysis: improving efficiency by using LC-MS systems with System Monitoring software
Improve the efficiency of PFAS and other high profile analysis using LC-MS systems with waters_connect System Monitoring software
